###begin article-title 0
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INI1</italic>
Secondary meningioma in a long-term survivor of atypical teratoid/rhabdoid tumour with a germline INI1 mutation
###end article-title 0
###begin title 1
Objective
###end title 1
###begin p 2
###xml 178 182 178 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INI1</italic>
###xml 15 22 <span type="species:ncbi:9606">patient</span>
We report on a patient who developed a meningioma more than two decades after removal at a young age of an atypical teratoid/rhabdoid tumour (AT/RT), which was due to a germline INI1 mutation, and radio- and chemotherapy.
###end p 2
###begin title 3
Materials and methods
###end title 3
###begin p 4
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INI1</italic>
We present genetic evidence that the meningioma is not a recurrence or metastasis of the AT/RT and not due to the INI1 mutation, but is a radiation-induced tumour.
###end p 4
###begin title 5
Conclusion
###end title 5
###begin p 6
###xml 211 215 211 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INI1</italic>
###xml 68 76 <span type="species:ncbi:9606">patients</span>
This is the first case illustrating that improved survival of young patients with an AT/RT after aggressive treatment may be gained at the cost of an increased risk for the development of radiation-induced, non-INI1-related tumours.
###end p 6
###begin title 7
Keywords
###end title 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 237 241 237 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INI1</italic>
###xml 243 244 243 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 458 462 458 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INI1</italic>
###xml 495 499 495 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INI1</italic>
###xml 554 557 554 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NF2</italic>
###xml 745 748 745 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NF2</italic>
###xml 772 776 772 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INI1</italic>
###xml 938 942 938 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INI1</italic>
###xml 1021 1022 1021 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 1209 1210 1209 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 637 644 <span type="species:ncbi:9606">patient</span>
###xml 1108 1115 <span type="species:ncbi:9606">patient</span>
###xml 1497 1504 <span type="species:ncbi:9606">patient</span>
We previously reported on a family in which four cousins developed an atypical teratoid/rhabdoid tumour (AT/RT) at young age, due to inheritance of a germline G>A mutation in the donor splice site of exon 4 of the tumour suppressor gene INI1 [2]. More than 20 years after resection of the AT/RT, the oldest of the four cousins developed an intracranial meningioma and, after an additional year, a myoepithelioma of the lip. In addition to the constitutional INI1 mutation and loss of the normal INI1 allele, we detected an identical rearrangement in the NF2 gene, not affecting its coding regions, in the AT/RT and myoepithelioma of the patient and concluded that they both originated from a common precursor cell. However, the rearrangement in NF2 and loss of the normal INI1 allele could not be demonstrated in the meningioma. Despite this, the development of the meningioma may be the consequence of the presence of the constitutional INI1 mutation, because mutations in this gene have been identified in meningiomas [8]. Alternatively, the meningioma could be induced by the radiation therapy, which our patient received after removal of the AT/RT and which is a well-known consequence of this treatment [1]. We investigated the meningioma for the presence of genetic changes reported in radiation-induced meningiomas and performed a comparative loss of heterozygosity (LOH) analysis to demonstrate that such radiation-induced genetic changes are absent in the AT/RT and myoepithelioma of our patient.
###end p 9
###begin title 10
Materials and methods
###end title 10
###begin title 11
Tumour samples and DNA isolation
###end title 11
###begin p 12
DNA from the AT/RT and the myoepithelioma was isolated from formalin-fixed and paraffin-embedded tumour material, and DNA from the meningioma was isolated from a fresh frozen tumour sample using commercially available kits (Qiagen, Venlo, The Netherlands).
###end p 12
###begin title 13
SNP analysis
###end title 13
###begin p 14
###xml 132 137 <span type="species:ncbi:9606">Human</span>
A genome-wide single nucleotide polymorphism (SNP) analysis of normal and meningioma DNA was conducted with the Affymetrix GeneChip Human Mapping 10K Array Xba 142 2.0. The array contains 10,204 SNPs distributed across the genome. The GeneChips were processed by an authorised Affymetrix Service Provider using standard Affymetrix protocols (Service XS, Leiden, The Netherlands). LOH regions were identified by comparing the SNP profiles of normal and meningioma DNA and scoring heterozygous SNP markers (AB) in the normal DNA that were reduced to homozygosity (AA or BB) in the meningioma DNA. Intervals were determined on the basis of locations of SNP markers in the UCSC Genome Browser, March 2006 Build, at .
###end p 14
###begin title 15
LOH analysis
###end title 15
###begin p 16
###xml 105 106 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
Loss of heterozygosity (LOH) analysis was performed with microsatellite markers as described previously [3] using primer sequences and conditions for polymerase chain reaction given by The Genome Database at . Because of rather extensive degradation of DNA extracted from the AT/RT, only markers generating PCR fragments smaller than 150 bp were used.
###end p 16
###begin title 17
Case report
###end title 17
###begin title 18
History
###end title 18
###begin p 19
###xml 334 335 334 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 4 11 <span type="species:ncbi:9606">patient</span>
###xml 1036 1043 <span type="species:ncbi:9606">patient</span>
Our patient was diagnosed with a tumour in the fourth ventricle and right cerebellar hemisphere at the age of 4.5 years. Resection of the tumour was incomplete. The tumour was originally classified as anaplastic ependymoma WHO grade III, but upon extensive genetic analysis and histopathological re-evaluation, reclassified as AT/RT [2]. He received adjuvant chemotherapy (methotrexate, vincristine and prednisolone) followed by craniospinal radiotherapy (3,300 cGy in 22 doses) with a boost of 2,100 cGy on the location of the tumour. Fifteen years later, a brain CT without contrast showed no signs of recurrent disease or of other new pathology. Almost 6 years later, 20.5 years after initial diagnosis, he presented again with bifrontal headaches, increasing ataxic gait disturbances and fatigue. CT examination showed a large isodens space-occupying lesion in the left temporal region with oedema, midline shift and contrast enhancement. One year after resection of this tumour, he developed a myoepithelioma of the upper lip. The patient is alive at 29 years of age.
###end p 19
###begin title 20
Histological findings
###end title 20
###begin p 21
###xml 166 167 166 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
Histopathological examination of the left temporal tumour revealed an atypical meningothelial meningioma WHO grade II with many vessels and up to six mitoses per 2 mm2.
###end p 21
###begin p 22
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SNP and LOH analysis</bold>
###xml 88 89 88 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 292 293 292 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 601 607 601 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D1S199</italic>
###xml 629 630 629 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 634 640 634 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D2S327</italic>
###xml 655 662 655 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D3S3727</italic>
###xml 683 684 683 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 688 696 688 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D16S3020</italic>
###xml 717 725 717 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D17S1872</italic>
###xml 749 750 749 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 793 794 793 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 822 829 822 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D22S430</italic>
###xml 838 839 838 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 942 948 942 948 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 999 1000 999 1000 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1014 1020 1014 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D1S199</italic>
###xml 1023 1024 1023 1024 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1037 1044 1037 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D3S3727</italic>
###xml 1047 1048 1047 1048 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1064 1072 1064 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D17S1872</italic>
###xml 1078 1079 1078 1079 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1085 1092 1085 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D22S430</italic>
###xml 1104 1105 1104 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1120 1121 1120 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 1143 1145 1143 1145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">My</italic>
###xml 1168 1169 1168 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 1234 1243 1234 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arrowhead</italic>
###xml 948 1277 948 1277 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="23">LOH analysis using markers from chromosome regions <bold>a</bold> 1pter-p34.3 (<italic>D1S199</italic>), <bold>b</bold> 3p26.1-cen (<italic>D3S3727</italic>), <bold>c</bold> 17qcen-q21.31 (<italic>D17S1872</italic>) and <bold>d</bold> 22q (<italic>D22S430</italic>) of AT/RT (<italic>A</italic>), meningioma (<italic>M</italic>) and myoepithelioma (<italic>My</italic>) DNAs of the patient. <italic>N</italic> denotes normal DNA derived from the patient&#8217;s blood leucocytes. <italic>Arrowhead</italic> indicates position of lost allele</p>
###xml 948 1277 948 1277 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="23">LOH analysis using markers from chromosome regions <bold>a</bold> 1pter-p34.3 (<italic>D1S199</italic>), <bold>b</bold> 3p26.1-cen (<italic>D3S3727</italic>), <bold>c</bold> 17qcen-q21.31 (<italic>D17S1872</italic>) and <bold>d</bold> 22q (<italic>D22S430</italic>) of AT/RT (<italic>A</italic>), meningioma (<italic>M</italic>) and myoepithelioma (<italic>My</italic>) DNAs of the patient. <italic>N</italic> denotes normal DNA derived from the patient&#8217;s blood leucocytes. <italic>Arrowhead</italic> indicates position of lost allele</p></caption>
###xml 1277 1277 1277 1277 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="381_2007_578_Fig1_HTML" id="MO1"/>
###xml 942 1277 942 1277 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="23">LOH analysis using markers from chromosome regions <bold>a</bold> 1pter-p34.3 (<italic>D1S199</italic>), <bold>b</bold> 3p26.1-cen (<italic>D3S3727</italic>), <bold>c</bold> 17qcen-q21.31 (<italic>D17S1872</italic>) and <bold>d</bold> 22q (<italic>D22S430</italic>) of AT/RT (<italic>A</italic>), meningioma (<italic>M</italic>) and myoepithelioma (<italic>My</italic>) DNAs of the patient. <italic>N</italic> denotes normal DNA derived from the patient&#8217;s blood leucocytes. <italic>Arrowhead</italic> indicates position of lost allele</p></caption><graphic position="anchor" xlink:href="381_2007_578_Fig1_HTML" id="MO1"/></fig>
###xml 1277 1284 1277 1284 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 1284 1344 1284 1344 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="24">LOH regions in the meningioma, as determined by SNP analysis</p>
###xml 1284 1344 1284 1344 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="24">LOH regions in the meningioma, as determined by SNP analysis</p></caption>
###xml 1344 1361 1344 1361 <th xmlns:xlink="http://www.w3.org/1999/xlink">Chromosome region</th>
###xml 1361 1380 1361 1380 <th xmlns:xlink="http://www.w3.org/1999/xlink">Exact interval (Mb)</th>
###xml 1344 1380 1344 1380 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>Chromosome region</th><th>Exact interval (Mb)</th></tr>
###xml 1344 1380 1344 1380 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th>Chromosome region</th><th>Exact interval (Mb)</th></tr></thead>
###xml 1380 1391 1380 1391 <td xmlns:xlink="http://www.w3.org/1999/xlink">1pter-p34.3</td>
###xml 1391 1398 1391 1398 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#x2013;" align="char">0&#8211;38.90</td>
###xml 1380 1398 1380 1398 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>1pter-p34.3</td><td char="&#8211;" align="char">0&#8211;38.90</td></tr>
###xml 1398 1406 1398 1406 <td xmlns:xlink="http://www.w3.org/1999/xlink">1p33-p33</td>
###xml 1406 1417 1406 1417 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#x2013;" align="char">46.99&#8211;51.09</td>
###xml 1398 1417 1398 1417 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>1p33-p33</td><td char="&#8211;" align="char">46.99&#8211;51.09</td></tr>
###xml 1417 1430 1417 1430 <td xmlns:xlink="http://www.w3.org/1999/xlink">1p32.2-1p31.3</td>
###xml 1430 1441 1430 1441 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#x2013;" align="char">58.19&#8211;65.50</td>
###xml 1417 1441 1417 1441 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>1p32.2-1p31.3</td><td char="&#8211;" align="char">58.19&#8211;65.50</td></tr>
###xml 1441 1450 1441 1450 <td xmlns:xlink="http://www.w3.org/1999/xlink">2pter-p12</td>
###xml 1450 1457 1450 1457 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#x2013;" align="char">0&#8211;79.28</td>
###xml 1441 1457 1441 1457 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>2pter-p12</td><td char="&#8211;" align="char">0&#8211;79.28</td></tr>
###xml 1457 1467 1457 1467 <td xmlns:xlink="http://www.w3.org/1999/xlink">3p26.1-cen</td>
###xml 1467 1477 1467 1477 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#x2013;" align="char">6.11&#8211;88.84</td>
###xml 1457 1477 1457 1477 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>3p26.1-cen</td><td char="&#8211;" align="char">6.11&#8211;88.84</td></tr>
###xml 1477 1488 1477 1488 <td xmlns:xlink="http://www.w3.org/1999/xlink">7q36.1-qter</td>
###xml 1488 1501 1488 1501 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#x2013;" align="char">150.04&#8211;158.66</td>
###xml 1477 1501 1477 1501 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>7q36.1-qter</td><td char="&#8211;" align="char">150.04&#8211;158.66</td></tr>
###xml 1501 1513 1501 1513 <td xmlns:xlink="http://www.w3.org/1999/xlink">16pter-p12.1</td>
###xml 1513 1520 1513 1520 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#x2013;" align="char">0&#8211;22.75</td>
###xml 1501 1520 1501 1520 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>16pter-p12.1</td><td char="&#8211;" align="char">0&#8211;22.75</td></tr>
###xml 1520 1533 1520 1533 <td xmlns:xlink="http://www.w3.org/1999/xlink">16q23.1-q23.3</td>
###xml 1533 1544 1533 1544 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#x2013;" align="char">73.46&#8211;81.33</td>
###xml 1520 1544 1520 1544 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>16q23.1-q23.3</td><td char="&#8211;" align="char">73.46&#8211;81.33</td></tr>
###xml 1544 1556 1544 1556 <td xmlns:xlink="http://www.w3.org/1999/xlink">17cen-q21.31</td>
###xml 1556 1567 1556 1567 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#x2013;" align="char">23.09&#8211;40.35</td>
###xml 1544 1567 1544 1567 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>17cen-q21.31</td><td char="&#8211;" align="char">23.09&#8211;40.35</td></tr>
###xml 1567 1579 1567 1579 <td xmlns:xlink="http://www.w3.org/1999/xlink">19pter-p13.2</td>
###xml 1579 1585 1579 1585 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#x2013;" align="char">0&#8211;8.83</td>
###xml 1567 1585 1567 1585 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>19pter-p13.2</td><td char="&#8211;" align="char">0&#8211;8.83</td></tr>
###xml 1380 1585 1380 1585 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>1pter-p34.3</td><td char="&#8211;" align="char">0&#8211;38.90</td></tr><tr><td>1p33-p33</td><td char="&#8211;" align="char">46.99&#8211;51.09</td></tr><tr><td>1p32.2-1p31.3</td><td char="&#8211;" align="char">58.19&#8211;65.50</td></tr><tr><td>2pter-p12</td><td char="&#8211;" align="char">0&#8211;79.28</td></tr><tr><td>3p26.1-cen</td><td char="&#8211;" align="char">6.11&#8211;88.84</td></tr><tr><td>7q36.1-qter</td><td char="&#8211;" align="char">150.04&#8211;158.66</td></tr><tr><td>16pter-p12.1</td><td char="&#8211;" align="char">0&#8211;22.75</td></tr><tr><td>16q23.1-q23.3</td><td char="&#8211;" align="char">73.46&#8211;81.33</td></tr><tr><td>17cen-q21.31</td><td char="&#8211;" align="char">23.09&#8211;40.35</td></tr><tr><td>19pter-p13.2</td><td char="&#8211;" align="char">0&#8211;8.83</td></tr></tbody>
###xml 1344 1585 1344 1585 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th>Chromosome region</th><th>Exact interval (Mb)</th></tr></thead><tbody><tr><td>1pter-p34.3</td><td char="&#8211;" align="char">0&#8211;38.90</td></tr><tr><td>1p33-p33</td><td char="&#8211;" align="char">46.99&#8211;51.09</td></tr><tr><td>1p32.2-1p31.3</td><td char="&#8211;" align="char">58.19&#8211;65.50</td></tr><tr><td>2pter-p12</td><td char="&#8211;" align="char">0&#8211;79.28</td></tr><tr><td>3p26.1-cen</td><td char="&#8211;" align="char">6.11&#8211;88.84</td></tr><tr><td>7q36.1-qter</td><td char="&#8211;" align="char">150.04&#8211;158.66</td></tr><tr><td>16pter-p12.1</td><td char="&#8211;" align="char">0&#8211;22.75</td></tr><tr><td>16q23.1-q23.3</td><td char="&#8211;" align="char">73.46&#8211;81.33</td></tr><tr><td>17cen-q21.31</td><td char="&#8211;" align="char">23.09&#8211;40.35</td></tr><tr><td>19pter-p13.2</td><td char="&#8211;" align="char">0&#8211;8.83</td></tr></tbody></table>
###xml 1277 1585 1277 1585 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="24">LOH regions in the meningioma, as determined by SNP analysis</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Chromosome region</th><th>Exact interval (Mb)</th></tr></thead><tbody><tr><td>1pter-p34.3</td><td char="&#8211;" align="char">0&#8211;38.90</td></tr><tr><td>1p33-p33</td><td char="&#8211;" align="char">46.99&#8211;51.09</td></tr><tr><td>1p32.2-1p31.3</td><td char="&#8211;" align="char">58.19&#8211;65.50</td></tr><tr><td>2pter-p12</td><td char="&#8211;" align="char">0&#8211;79.28</td></tr><tr><td>3p26.1-cen</td><td char="&#8211;" align="char">6.11&#8211;88.84</td></tr><tr><td>7q36.1-qter</td><td char="&#8211;" align="char">150.04&#8211;158.66</td></tr><tr><td>16pter-p12.1</td><td char="&#8211;" align="char">0&#8211;22.75</td></tr><tr><td>16q23.1-q23.3</td><td char="&#8211;" align="char">73.46&#8211;81.33</td></tr><tr><td>17cen-q21.31</td><td char="&#8211;" align="char">23.09&#8211;40.35</td></tr><tr><td>19pter-p13.2</td><td char="&#8211;" align="char">0&#8211;8.83</td></tr></tbody></table></table-wrap>
###xml 1159 1166 <span type="species:ncbi:9606">patient</span>
###xml 1206 1213 <span type="species:ncbi:9606">patient</span>
SNP and LOH analysis Radiation-induced meningiomas usually display a complex karyotype [1]. To determine the genetic changes, we performed a genome-wide scan by SNP analysis of the meningioma and corresponding normal DNA. The identified chromosomal regions displaying LOH are listed in Table 1. Next, we tested several markers from within each of the five largest deleted regions by conventional microsatellite analysis to determine their LOH status in the meningioma and in the AT/RT and myoepithelioma. Presence of LOH in the meningioma, but absence of LOH in AT/RT and myoepithelioma was found for D1S199 in 1pter-p34.3 (Fig. 1a), D2S327 in 2pter-p12, D3S3727 in 3p26.1-cen (Fig. 1b), D16S3020 in 16pter-p12.1 and D17S1872 in 17qcen-q21.31 (Fig. 1c). In contrast, as determined previously [2] and exemplified by marker D22S430 in Fig. 1d, there was LOH for chromosome 22 markers in the AT/RT and myoepithelioma, but not in the meningioma. Fig. 1LOH analysis using markers from chromosome regions a 1pter-p34.3 (D1S199), b 3p26.1-cen (D3S3727), c 17qcen-q21.31 (D17S1872) and d 22q (D22S430) of AT/RT (A), meningioma (M) and myoepithelioma (My) DNAs of the patient. N denotes normal DNA derived from the patient's blood leucocytes. Arrowhead indicates position of lost alleleTable 1LOH regions in the meningioma, as determined by SNP analysisChromosome regionExact interval (Mb)1pter-p34.30-38.901p33-p3346.99-51.091p32.2-1p31.358.19-65.502pter-p120-79.283p26.1-cen6.11-88.847q36.1-qter150.04-158.6616pter-p12.10-22.7516q23.1-q23.373.46-81.3317cen-q21.3123.09-40.3519pter-p13.20-8.83
###end p 22
###begin p 23
###xml 51 52 51 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 66 72 66 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D1S199</italic>
###xml 75 76 75 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 89 96 89 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D3S3727</italic>
###xml 99 100 99 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 116 124 116 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D17S1872</italic>
###xml 130 131 130 131 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 137 144 137 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D22S430</italic>
###xml 156 157 156 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 172 173 172 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 195 197 195 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">My</italic>
###xml 220 221 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 286 295 286 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arrowhead</italic>
###xml 211 218 <span type="species:ncbi:9606">patient</span>
###xml 258 265 <span type="species:ncbi:9606">patient</span>
LOH analysis using markers from chromosome regions a 1pter-p34.3 (D1S199), b 3p26.1-cen (D3S3727), c 17qcen-q21.31 (D17S1872) and d 22q (D22S430) of AT/RT (A), meningioma (M) and myoepithelioma (My) DNAs of the patient. N denotes normal DNA derived from the patient's blood leucocytes. Arrowhead indicates position of lost allele
###end p 23
###begin p 24
LOH regions in the meningioma, as determined by SNP analysis
###end p 24
###begin title 25
Discussion
###end title 25
###begin p 26
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INI1</italic>
###xml 299 300 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 327 331 327 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INI1</italic>
###xml 376 377 376 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 476 480 476 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INI1</italic>
###xml 570 574 570 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INI1</italic>
###xml 624 625 624 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 627 628 627 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 630 631 630 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 752 753 752 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 817 821 817 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INI1</italic>
###xml 874 875 874 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 954 958 954 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INI1</italic>
###xml 1078 1079 1078 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 1081 1082 1081 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 1084 1085 1084 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 1157 1158 1157 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 1263 1266 1263 1266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NF2</italic>
###xml 1273 1274 1273 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 1383 1384 1383 1384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 195 202 <span type="species:ncbi:9606">patient</span>
###xml 778 785 <span type="species:ncbi:9606">patient</span>
In a previous study, we provided evidence for the involvement of INI1, by constitutional mutation and independent somatic loss, in the development of both the AT/RT and the myoepithelioma of our patient. Moreover, we could demonstrate that these tumours originated from an identical precursor cell [2]. Although involvement of INI1 has been described in sporadic meningiomas [8], until now meningiomas have not been reported to occur as a consequence of the inheritance of an INI1 mutation. However, this might be due to the extreme rarity of families with an inherited INI1 mutation, with only four published cases so far [2, 5, 6, 11]. In this context, it is interesting to note that (as demonstrated before and exemplified by marker D22S430 in Fig. 1d) the meningioma of our patient has no LOH 22 and the retained INI1 allele carries no additional inactivating mutation [2], indicating that this tumour is not the result of inheritance of the mutated INI1 gene. In contrast, the meningioma displayed genetic changes that are characteristic for radiation-induced meningiomas [1, 7, 9], such as a complex karyotype, as evidenced by the SNP analysis (Table 1), including extensive losses on chromosome arm 1p, but no loss of chromosome 22, and no mutation in the NF2 gene [2]. The genetic changes found in the meningioma proved not to be present in the AT/RT or myoepithelioma (Fig. 1a-c, and data not shown), demonstrating that the meningioma is genetically not related to these tumours and should not be considered as a late and more differentiated recurrence or metastasis of the AT/RT.
###end p 26
###begin p 27
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 732 733 732 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 212 220 <span type="species:ncbi:9606">patients</span>
###xml 815 822 <span type="species:ncbi:9606">patient</span>
In conclusion, the clinical and genetic characteristics of the meningioma clearly indicate that the tumour developed as a consequence of the radiation therapy. Recent evidence suggests that long-term survival of patients with a childhood AT/RT can occur especially after aggressive treatment including radiotherapy [10, 12]. The possible late effects of radiation therapy have been considered as serious drawbacks of this treatment. This is the first case in literature in which such a possible consequence in the form of a radiation-induced meningioma is actually documented in a long-term survivor of an AT/RT. Compared to sporadic meningiomas, radiation-induced meningiomas are more aggressive and have a higher chance to recur [1]. Because of this unfavourable prognosis, continuous medical surveillance of our patient is warranted.
###end p 27
###begin title 28
Acknowledgement
###end title 28
###begin p 29
We gratefully acknowledge the financial support from the Dutch Cancer Society, grants KUN 2003-2975 (PW) and UVA 2001-2561 (TH).
###end p 29
###begin p 30
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 30
###begin title 31
References
###end title 31
###begin article-title 32
Radiation-induced meningiomas: clinical, pathological, cytokinetic, and cytogenetic characteristics
###end article-title 32
###begin article-title 33
Molecular analysis of genetic changes in ependymomas
###end article-title 33
###begin article-title 34
Radiation-induced meningiomas: experience at the Mount Sinai Hospital and review of the literature
###end article-title 34
###begin article-title 35
Germline mutation of INI1/SMARCB1 in familial schwannomatosis
###end article-title 35
###begin article-title 36
Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutation
###end article-title 36
###begin article-title 37
Molecular genetics of meningiomas
###end article-title 37
###begin article-title 38
INI1 mutations in meningiomas at a potential hotspot in exon 9
###end article-title 38
###begin article-title 39
Radiation-induced meningioma: a distinct molecular genetic pattern
###end article-title 39
###begin article-title 40
Atypical teratoid/rhabdoid tumor: the controversy behind radiation therapy
###end article-title 40
###begin article-title 41
Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene
###end article-title 41
###begin article-title 42
###xml 63 71 <span type="species:ncbi:9606">children</span>
Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy
###end article-title 42

